Literature DB >> 9630295

Overview of studies on metabolic and vascular regulatory changes in early diabetic retinopathy.

V A Alder1, E N Su, D Y Yu, S Cringle, P Yu.   

Abstract

The present review provides an overview of recent research describing functional changes to the retinal vasculature in very early diabetes. The research focuses on the streptozotocin rat model after 4-6 weeks of induced diabetes and describes functional changes to retinal blood flow, vascular control and retinal oxygenation, as well as a strong vasodilatory response to insulin in the retinal vasculature. The review raises the question of whether choroid dysfunction is also a feature of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630295     DOI: 10.1111/j.1442-9071.1998.tb01530.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  4 in total

1.  Magnetic resonance imaging of tissue and vascular layers in the cat retina.

Authors:  Qiang Shen; Haiying Cheng; Machelle T Pardue; Thomas F Chang; Govind Nair; Van Toi Vo; Ross D Shonat; Timothy Q Duong
Journal:  J Magn Reson Imaging       Date:  2006-04       Impact factor: 4.813

Review 2.  From pathobiology to the targeting of pericytes for the treatment of diabetic retinopathy.

Authors:  Joseph F Arboleda-Velasquez; Cammi N Valdez; Christina K Marko; Patricia A D'Amore
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

Review 3.  The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function.

Authors:  Sergey Shityakov; Michiaki Nagai; Süleyman Ergün; Barbara M Braunger; Carola Y Förster
Journal:  Biomolecules       Date:  2022-08-12

4.  Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.

Authors:  Gangadhar Sunkara; Surya P Ayalasomayajula; Cheruku S Rao; Jonathan L Vennerstrom; Jack DeRuiter; Uday B Kompella
Journal:  J Pharm Pharmacol       Date:  2004-03       Impact factor: 3.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.